What is the address of BIOCERAM?

The registered office of BIOCERAM is located at Terhulpensesteenweg 422, 3090 Overijse.

Is BIOCERAM still active?

Yes. According to the CBE (15 November 2026) BIOCERAM is active, legal situation “Normale toestand”, started on 27 October 2004.

Is BIOCERAM registered on Peppol?

Yes, BIOCERAM is registered on the Peppol network with ID 0208:0869701307.

What is the enterprise number of BIOCERAM?

The enterprise number of BIOCERAM is BE0869701307.

When was BIOCERAM founded?

BIOCERAM was founded on 27 October 2004.

Who are the directors of BIOCERAM?

According to the 2025 annual accounts, the directors of BIOCERAM are: XAVIER RUTTIENS, VINCENT DELESCAILLE.

Is BIOCERAM a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 27 October 2004; 4 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did BIOCERAM make in 2025?

BIOCERAM posted a profit after taxes of € 132,135 in financial year 2025.

What is the revenue of BIOCERAM?

As a small company, BIOCERAM is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 828,511.

How much does an employee at BIOCERAM earn?

The average wage cost per full-time employee at BIOCERAM was € 67,300 in 2025: staff costs of € 605,402 for 9 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does BIOCERAM have?

According to the 2025 annual accounts, BIOCERAM has 9 full-time equivalents (FTE).

BIOCERAM (Private Limited) - Overijse - BE0869701307

Q: What does BIOCERAM do?

BIOCERAM is registered with the CBE as active in: Vervaardiging van medische en tandheelkundige instrumenten en benodigdheden. Private Limited, started on 27 October 2004, 1 establishment.

Dossier BIOCERAM, printed on 15 November 2026 from databakkes.be/en/0869701307/bioceram. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

BIOCERAM from Overijse, company number BE0869701307, closed financial year 2025 with a result of € 132,135 after tax. For that financial year BIOCERAM recorded a gross margin of € 828,511 and equity of € 638,400. Compared with financial year 2024, the result moved from € 281,716 to € 132,135. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on March 31, 2026.

What it is worth Growing

€ 638,400

▲ 26% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 132,135

▼ 53% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 448,842

▲ 16% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 619,800.

People and assets in 2025

Full-time equivalents

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 605,402

▲ 11% vs 2024

€ 67,300 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 5,030

▼ 26% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 27,167

▲ 90% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 161,068

▲ 215% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 108,893

▼ 25% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 427,243 Gross margin 2022: € 427,243 First fiscal year in the series	€ 538,452 Gross margin 2023: € 538,452 ▲ 26% vs 2022 (€ 427,243) Favourable step	€ 963,716 Gross margin 2024: € 963,716 ▲ 79% vs 2023 (€ 538,452) Favourable step	€ 828,511 Gross margin 2025: € 828,511 ▼ 14% vs 2024 (€ 963,716) Unfavourable step	▼ 14%
Profit after taxes	€ 187 Profit after taxes 2022: € 187 First fiscal year in the series	€ -61,809 Profit after taxes 2023: € -61,809 ▼ € 61,996 vs 2022 (€ 187) Unfavourable step	€ 281,716 Profit after taxes 2024: € 281,716 ▲ € 343,525 vs 2023 (€ -61,809) Favourable step	€ 132,135 Profit after taxes 2025: € 132,135 ▼ 53% vs 2024 (€ 281,716) Unfavourable step	▼ 53%
Equity	€ 286,642 Equity 2022: € 286,642 First fiscal year in the series	€ 224,549 Equity 2023: € 224,549 ▼ 22% vs 2022 (€ 286,642) Unfavourable step	€ 506,265 Equity 2024: € 506,265 ▲ 125% vs 2023 (€ 224,549) Favourable step	€ 638,400 Equity 2025: € 638,400 ▲ 26% vs 2024 (€ 506,265) Favourable step	▲ 26%
Total debts	€ 197,919 Total debts 2022: € 197,919 First fiscal year in the series	€ 151,668 Total debts 2023: € 151,668 ▼ 23% vs 2022 (€ 197,919) Favourable step	€ 209,962 Total debts 2024: € 209,962 ▲ 38% vs 2023 (€ 151,668) Unfavourable step	€ 297,128 Total debts 2025: € 297,128 ▲ 42% vs 2024 (€ 209,962) Unfavourable step	▲ 42%
Cash	€ 15,456 Cash 2022: € 15,456 First fiscal year in the series	€ 31,829 Cash 2023: € 31,829 ▲ 106% vs 2022 (€ 15,456) Favourable step	€ 386,318 Cash 2024: € 386,318 ▲ € 354,489 vs 2023 (€ 31,829) Favourable step	€ 448,842 Cash 2025: € 448,842 ▲ 16% vs 2024 (€ 386,318) Favourable step	▲ 16%
Retained profit	€ 267,458 Retained profit 2022: € 267,458 First fiscal year in the series	€ 205,949 Retained profit 2023: € 205,949 ▼ 23% vs 2022 (€ 267,458) Unfavourable step	€ 487,665 Retained profit 2024: € 487,665 ▲ 137% vs 2023 (€ 205,949) Favourable step	€ 619,800 Retained profit 2025: € 619,800 ▲ 27% vs 2024 (€ 487,665) Favourable step	▲ 27%
Bank debt	€ 48,242 Bank debt 2022: € 48,242 First fiscal year in the series	€ 22,695 Bank debt 2023: € 22,695 ▼ 53% vs 2022 (€ 48,242) Favourable step	€ 14,291 Bank debt 2024: € 14,291 ▼ 37% vs 2023 (€ 22,695) Favourable step	€ 27,167 Bank debt 2025: € 27,167 ▲ 90% vs 2024 (€ 14,291) Unfavourable step	▲ 90%
Balance sheet total	€ 484,862 Balance sheet total 2022: € 484,862 First fiscal year in the series	€ 376,217 Balance sheet total 2023: € 376,217 ▼ 22% vs 2022 (€ 484,862) Unchanged	€ 716,227 Balance sheet total 2024: € 716,227 ▲ 90% vs 2023 (€ 376,217) Unchanged	€ 935,528 Balance sheet total 2025: € 935,528 ▲ 31% vs 2024 (€ 716,227) Unchanged	▲ 31%
Employees (FTE)	-	-	-	9 Employees (FTE) 2025: 9 First fiscal year in the series

By gross margin, BIOCERAM ranks 9th of 81 companies with main activity “Vervaardiging van medische en tandheelkundige instrumenten en benodigdheden” in Flemish Brabant that publish figures (fiscal year 2025).

Key figures of BIOCERAM, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.

Ask about BIOCERAM the way you would ask their accountant.

Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.

Connect ChatGPT or Claude for free

ChatGPT
Claude

Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.

What happened to BIOCERAM?

What happened at BIOCERAM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Mar 31, 2026 New annual accounts for financial year 2025: profit of € 132,135 (▼ 53% vs 2024). Source: NBB ↗
Oct 27, 2004 New establishment in Overijse. KBO
Oct 27, 2004 Start of the company according to the CBE. KBO

In short

From € 187 profit in 2022 to € 132,135 profit in 2025.

Paid € 176,444 in corporate taxes since 2022.

Best year ever: 2024, with € 281,716 profit.

On average € 92,100 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

XAVIER RUTTIENS VINCENT DELESCAILLE

XV DENTAL

BIOCERAM

Behind BIOCERAM are XAVIER RUTTIENS and VINCENT DELESCAILLE. The same people are also behind XV DENTAL.

Directors

According to the 2025 annual accounts

XAVIER RUTTIENS

Manager

Also active at: XV DENTAL

VINCENT DELESCAILLE

Manager

Also active at: XV DENTAL

Establishments

Establishment units

Physical locations of this company

Registered office

Terhulpensesteenweg 422

3090 Overijse

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

XV DENTAL same network

€ 84,272 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Similar companies in Flemish Brabant

Same main activity (Vervaardiging van medische en tandheelkundige instrumenten en benodigdheden), 112 active companies in Flemish Brabant, largest first.

TERUMO EUROPE

€ 799.2 million revenue · 2026 · Leuven

SIEMENS HEALTHCARE

€ 454.7 million revenue · 2025 · Dilbeek

MATERIALISE

€ 181 million revenue · 2025 · Leuven

GE HEALTHCARE

€ 103.4 million revenue · 2025 · Machelen (Brab.)

GC Manufacturing Europe

€ 68.5 million revenue · 2026 · Leuven

Medline International Belgium

€ 36.2 million revenue · 2025 · Machelen (Brab.)

All companies with this activity → Largest companies in Overijse →

Details

Company number

0869.701.307

VAT number

BE 0869.701.307

Registered office

Terhulpensesteenweg 422, 3090 Overijse

Names & denominations

BIOCERAM

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

27 October 2004

Peppol

Active · Active since 10 Oct 2025

Activities · NACE

Vervaardiging van medische en tandheelkundige instrumenten en benodigdheden

Vervaardiging van orthopedische artikelen en prothesen

View on CBE Public ↗ Annual accounts (NBB) ↗

BIOCERAM

Financials

Ask about BIOCERAM the way you would ask their accountant.

What happened to BIOCERAM?

Management

Directors

Establishments

Establishment units

Who else lives here?

Similar companies in Flemish Brabant

Details

Frequently asked questions